| 1. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1130KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 2. |
Angiotensin II antagonistsvsACE inhibitors: the debate |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 3-5
Gill Higgins,
Preview
|
PDF (3267KB)
|
|
摘要:
Because both the angiotensin II antagonists and the ACE inhibitors exert their beneficial effects by blocking the activity of angiotensin II, they are destined for constant comparison. However, at present, leading cardiologists appear to be waiting for further clinical data on the angiotensin II antagonists before making any strong claims for the advantages of one class over another. A preliminary discussion of the profiles of the 2 drug classes took place during several sessions at the 6th International Symposium on Cardiovascular Pharmacotherapy [Sydney, Australia; February 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 3. |
Views on managing PCP |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1110KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 4. |
NSAID and analgesic prescribing inappropriate in the UK |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 7-7
&NA;,
Preview
|
PDF (1017KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 5. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1016KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 6. |
Trials begin for unique immunomodulatory anticancer agent |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 9-10
Gill Higgins,
Preview
|
PDF (2065KB)
|
|
摘要:
NSC-640488 is thought to be the first anticancer agent of its kind to reach clinical trials. The drug has a unique immunomodulatory mechanism of action, which may eventually provide a form of treatment that is complementary to conventional antineoplastic therapy. While there is still much to be learnt about NSC-640488 and how it exerts its effect, the results of preclinical investigations provide an interesting introduction to this novel agent. These findings were presented at the 25th Jubilee Conference of the New Zealand Society for Oncology [Auckland, New Zealand; February 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 7. |
Interferon gene makes tumours suppress themselves |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1046KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 8. |
Acrivastine/pseudoephedrine effective in allergic rhinitis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 11-11
&NA;,
Preview
|
PDF (965KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 9. |
Women's risk of complications with thrombolytics after MI |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 12-12
&NA;,
Preview
|
PDF (1081KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
| 10. |
New studies in ischaemic stroke & subarachnoid haemorrhage |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1029,
1996,
Page 13-14
Robert Carlson,
Preview
|
PDF (2048KB)
|
|
摘要:
A number of new studies are underway to investigate potential treatments for ischaemic stroke and subarachnoid haemorrhage. The rationale behind the trials and details of their design were presented at the American Heart Association's 21st International Joint Conference on Stroke and Cerebral Circulation [San Antonio, Texas, US; January 1996]. In addition, the results of a trial studying the effects of piracetam in ischaemic stroke were reported.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
首页
